These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Minimizing the risk of posttransplant malignancy. Campistol JM Transplantation; 2009 Apr; 87(8 Suppl):S19-22. PubMed ID: 19384182 [TBL] [Abstract][Full Text] [Related]
36. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients. Touraine JL; Garnier JL; Lefrancois N; Finaz de Villaine J; Dubernard JM; de Thé G; Lenoir G Transplant Proc; 1989 Feb; 21(1 Pt 3):3197-8. PubMed ID: 2650450 [No Abstract] [Full Text] [Related]
37. Kaposi sarcoma in a patient with giant cell arteritis. Kuttikat A; Joshi A; Saeed I; Chakravarty K Dermatol Online J; 2006 Oct; 12(6):16. PubMed ID: 17083896 [TBL] [Abstract][Full Text] [Related]
38. A case of Kaposi's sarcoma following treatment of membranoproliferative glomerulonephritis and a review of the literature. Agbaht K; Pepedil F; Kirkpantur A; Yilmaz R; Arici M; Turgan C Ren Fail; 2007; 29(1):107-10. PubMed ID: 17365919 [TBL] [Abstract][Full Text] [Related]
40. For organ transplant recipients, cancer threatens long-term survival. Ross K J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]